Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Tuberous Sclerosis × Urination × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Tuberous Sclerosis 1 Smoldering Multiple Myeloma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Monoclonal Gammopathy of Undetermined Significance 1 Lymphangioleiomyomatosis 1 Lung Neoplasms 1 Disease 1

Interventions

Sirolimus 9 Everolimus 9 ganaxolone 2 Melatonin 2 Activator Appliances 2 radiprodil 1 Vigabatrin 1 Urination 1 Simvastatin 1 Propranolol 1 Doxycycline 1 Cannabidiol 1 Calcitriol 1 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05323370 2023-03-29

LAM-CAK

University Hospital, Tours

Tuberous Sclerosis, Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡